Endoscopy Device Market Overview
The Endoscopy Devices Market Size was valued at USD 20.27 billion in 2023 and is projected to grow from USD 21.45 Billion in 2024 to USD 31.07 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.20% during the forecast period (2024 - 2032).The primary market driver projected to propel market expansion throughout the forecast period are the less invasive characteristics and low post- and pre-procedure costs of endoscopic equipment.
In January 2023, AA Medical partnered with Certified Endoscopy Products, a Chicago-based medical device reprocessing company specializing in endoscopic devices. AA Medical and Certified Endoscopy will create a leading medical device reprocessing company for the endoscopy, orthopedic and other surgical device markets.
Also, PENTAX Medical launched the Performance Endoscopic Ultrasound (EUS) system in Canada in November 2022.
August 2022 saw the unveiling of GI Genius by Medtronic, which is an artificial intelligence endoscopy module aimed at treating colon cancer across India. The developed medical solution offers real-time information that helps doctors to detect and treat colorectal cancer while ensuring enhanced visualization during colonoscopy.
Zsquare got FDA 510K clearance to sell its product Zsquare ENT-Flex Rhinolaryngoscope in July 2022 as a single-use endoscopes developer.
Also, Getinge introduced a new updated version of the ED-Flow automated endoscope reprocessor that has a higher level of digital connectivity and data management for Getinge's customers who have purchased the company’s endoscope reprocessors would help improve the uptime and productivity of manufacturing equipment.
For example, in April 2022, Fujifilm introduce the mobile training hub called “EndoRunner Tour,” where EndoRunner will visit hospitals and conferences all over Europe during the European Society of Gastrointestinal Endoscopy conference. That launch was meant to counteract post-COVID infection challenges within endoscopy itnerventions. It was anticipated that the emergence of new variants on COVID-19 will have minimal impacts on the market for these endoscopic devices. The market is also expected to register steady growth throughout the forecast period.
For instance, FUJIFILM Healthcare brought a dual-channel endoscope cleared by the United States Food and Drug Administration for upper and lower gastrointestinal applications in November 2021.
For instance, in August 2021, the Food and Drug Administration approved Boston Scientific’s EXALT Model B Single-Use Bronchoscope. Flexible bronchoscopy has come of age with the advent of the latest-generation technology called EXALT Model B Single-Use Bronchoscope, designed for use in ICU to help maintain airway patency during complex respiratory procedures like double-lumen tube placements.
Endoscopy Device Market Trends
-
Rising prevalence and incidence of gastrointestinal disorders to propel market growth
The market for endoscopy device is being driven by the increase in the incidence and prevalence rates of gastrointestinal (GI) disorders. The market is being supported by the rising prevalence of gastrointestinal disorders such as colorectal cancer, gastroesophageal reflux disease, ulcerative colitis (UC), inflammatory bowel disease (IBD), and Crohn's disease (CD). Endoscopic instruments are used to undertake minimally invasive or non-invasive surgical procedures to treat life-threatening disorders. The prevalence of gastrointestinal conditions, including cancer is highest in Asian nations. In Korea, where there are 39.6 cancer cases per 100,000 people, Japan, with 27.5 cases per 100,000 people, and Mongolia, with 33.1 cases, are rated 1, 2, and 3 correspondingly. The need for endoscopic devices is expanding in developing nations due to the increased frequency of GI illnesses and the strong demand for minimally invasive surgical treatments. This is fueling the market for endoscopy device to increase. Thus, this factor is driving the market CAGR for endoscopy device.
Furthermore, increasingly more individuals are living sedentary lifestyles due to urbanization and rising disposable incomes worldwide. Obesity rates are rising, particularly in industrialized nations like North America and Europe. In the US, obesity will affect 36.2% of the population in 2021. This is the reason why bariatric surgical operations are becoming more and more popular. In 2020, there were over 297,000 bariatric procedures just in the US. Since doctors use endoscopy equipment both before and during surgery, this is pushing the demand for it. Laparoscopes are utilized during the surgical process, and endoscopy is performed beforehand to evaluate the gastrointestinal tract for any abnormalities.
However, around 727 million people over 65 made up 9.3% of the world's population in 2020. By 2050, 16% of the population will be elderly, according to predictions. During the projected period, the senior population is expected to expand rapidly in the US, Canada, Europe, India, and China, among other places. With aging comes an increased risk of developing diseases, including polyp growth, gastrointestinal obstructions, cancer, ulcers, and cancer. Because it is minimally invasive and causes the patient less discomfort, endoscopy is preferable to standard surgery for diagnosing and treating such disorders. Thus, it is anticipated that this aspect will accelerate endoscopy device market revenue globally.
Endoscopy devices Market Segment Insights
Endoscopy Device Type Insights
The endoscopy device market segmentation, based on type, includes rigid endoscopes, flexible endoscopes, surgical endoscopes, capsule endoscopes and robot-assisted endoscopes. The flexible endoscopes segment held the majority share in 2022 in the endoscopy device market data. Flexible endoscopes and expanding technological breakthroughs in this field are driving forces behind the growth of the minimally invasive treatments market. Over the projected period, manufacturers' focus on ensuring the best possible usage of cutting-edge flexible endoscopes is likely to drive market expansion.
Endoscopy Device Therapy Insights
The market segments of endoscopy device, based on therapy, includes colonoscopy, arthroscopy, gastroscopy, laparoscopy, sigmoidoscopy and ureteroscopy. The laparoscopy segment dominated the market growth for endoscopy device in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is due to the increased use of laparoscopic equipment in routine diagnostic and treatments for various illnesses, including prostatectomy, pancreatic cancer, and digestive issues. Additionally, the primary factor propelling the growth of the endoscopy device market is the rise in incidences of morbid obesity on a scale.
Endoscopy Device Treatment & Procedure Insights
The endoscopy device market data, based on treatment & procedure, includes lower gastrointestinal conditions, Joint and orthopedic conditions, lung and airway conditions, upper gastrointestinal conditions, abdominal and gynecologic. The upper gastrointestinal conditions segment dominated the endoscopy device market revenue for endoscopy device in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Ulcers, tumors, and celiac disorders are just a few problems that can be diagnosed and treated by upper gastrointestinal (GI) endoscopy. As a result, the huge market share of this sector can be attributed to the high prevalence of disorders that call for focused therapy.
Endoscopy Device Application Insights
The endoscopy device industry, based on application, includes arthroscopy, gastrointestinal endoscopy, obstetrics/gynecology endoscopy, urology endoscopy and mediastinoscopy. The gastrointestinal endoscopy segment dominated the market for endoscopy device in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The increased elderly population and the burden of functional gastrointestinal illnesses are to blame for this high segment share. The availability of technologically sophisticated endoscopes and the growing desire for endoscopic procedures as first-line treatments for the early detection and diagnosis of functional gastrointestinal problems are some of the other key factors promoting the segment's rise.
Endoscopy Device End User Insights
The endoscopy device industry, based on end user, includes Critical care, Obstetricians-gynecologists (ob/gyns), General and pediatric surgeons and Gastroenterologists. The gastroenterologists segment dominated the market for endoscopy device in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030 since it serves as the principal health facility in most nations. Furthermore, compared to alternative healthcare systems like specialist clinics or ambulatory surgery centres, the total number of endoscopic procedures performed in gastroenterologists.
Endoscopy Device Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America endoscopy device market accounted for USD 8.8 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. This can be attributable to the rising incidence of several chronic diseases, including functional gastrointestinal disorders, diabetes, and cancer. Additionally, the growing elderly population and their propensity for a number of chronic diseases are driving this area's adoption of endoscopic operations.
Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Asia Pacific endoscopy device market accounts for the second-largest market share due to the substantial population and rising prevalence of people with functional gastrointestinal disorders. The market expansion of the region is also expected to be accelerated by rising demand for minimally invasive endoscopic technique and improved healthcare infrastructure. Moreover, China market of endoscopy device held the largest market share, and the India market of endoscopy device was the fastest growing market in the region.
Europe endoscopy device Market is expected to grow at the fastest CAGR from 2022 to 2030. One of the main drivers of the regional market growth is the increasing demand of people for minimally invasive procedures. Additionally, growing government measures to update healthcare facilities and continually expand the start-up scene are among the key elements supporting the expansion of the market in the area. Further, the UK market of endoscopy device held the largest market share, and the Germany market of endoscopy device was the fastest growing market in the region.
Endoscopy Devices Market Key Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of endoscopy device grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the endoscopy device industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the endoscopy device industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, endoscopy device industry has provided medicine with some of the most significant benefits. The endoscopy device market major player such as Cogentix Medical, Integrate Endoscopy, J&J Services Inc., Shaili Endoscopy, Interscope Inc., Cantel Medical, Micro-Tech Endoscopy, Cognetix, Stryker and OLYMPUS.
The American corporation Cantel Medical Corporation manufactures and markets medical supplies. Its headquarters are in Little Falls, New Jersey. In December 2020, a new long-term partnership between CANTEL MEDICAL CORP. and CENSIS Technology was recently announced. It will combine Censis' surgical asset monitoring and instrument monitoring solutions with Cantel's leading endoscope reprocessing workflow portfolio for infection control.
The Japanese company Olympus Corporation produces devices for optics and reprography. On October 12, 1919, Olympus was founded, initially specialising in thermometers and microscopes. A market for endoscopes estimated to be worth about US$2.5 billion is one that Olympus controls roughly 70% of. In April 2020, the EVIS X1 endoscopy system was introduced by Olympus Corporation for the diagnosis and screening of conditions affecting the oesophagus, colon, and stomach as well as bronchial ailments.
Key Companies in the market of endoscopy device includes
-
Cogentix Medical
-
Integrate Endoscopy
-
J&J Services Inc.
-
Shaili Endoscopy
-
Interscope Inc.
-
Cantel Medical
-
Micro-Tech Endoscopy
-
Cognetix
-
Stryker
-
OLYMPUS
Endoscopy Devices Industry Developments
June 2022:For its endoscope reprocessing customers, Getinge has developed an enhanced model of the ED-Flow automated endoscope reprocessor with better levels of digital connectivity and data management, which will increase uptime and productivity.
April 2022:German endoscopy equipment manufacturer KARL STORZ has issued an urgent medical device recall notice for a number of its flexible endoscope products after discovering problems with the product's description and usage instructions as well as a possible risk of damage.
Endoscopy Device Market Segmentation
Endoscopy Device Type Outlook
Endoscopy Device Treatment Outlook
-
Colonoscopy
-
Arthroscopy
-
Gastroscopy
-
Laparoscopy
-
Sigmoidoscopy
-
Ureteroscopy
Endoscopy Device Treatment & Procedure Outlook
-
LOWER GASTROINTESTINAL CONDITIONS
-
JOINT AND ORTHOPEDIC CONDITIONS
-
LUNG AND AIRWAY CONDITIONS
-
UPPER GASTROINTESTINAL CONDITIONS
-
ABDOMINAL
-
GYNECOLOGIC
Endoscopy Device Application Outlook
Endoscopy Device End User Outlook
Endoscopy Device Regional Outlook
North America
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Australia
-
Rest of Asia-Pacific
Rest of the World
-
Middle East
-
Africa
-
Latin America
| Report Attribute/Metric |
Details |
| Market Size 2023 |
USD 20.27 billion |
| Market Size 2024 |
USD 21.45 billion |
| Market Size 2032 |
USD 31.07 billion |
| Compound Annual Growth Rate (CAGR) |
4.20% (2024-2032) |
| Base Year |
2022 |
| Market Forecast Period |
2024-2032 |
| Historical Data |
2018 - 2021 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Type, Therapy, Treatment & Procedure, Application, End User and Region |
| Geographies Covered |
North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered |
The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled |
Cogentix Medical, Integrate Endoscopy, J&J Services Inc., Shaili Endoscopy, Interscope Inc., Cantel Medical, Micro-Tech Endoscopy, Cognetix, Stryker and OLYMPUS |
| Key Market Opportunities |
Expanding Therapeutic Capability Of Endoscopy Instruments Creates Growth Avenues for Key Players |
| Key Market Dynamics |
Increasing Prevalence of Chronic Diseases |
Endoscopy Devices Market Highlights:
Frequently Asked Questions (FAQ) :
The global market for endoscopy device is further segmented based on therapy into arthroscopy, colonoscopy, cystoscopy, endoscopic retrograde cholangiopancreatography, gastroscopy, laparoscopy, sigmoidoscopy, and ureteroscopy.
The CAGR of Endoscopy Device Market would be 4.20% during the forecast period of 2024 to 2032.
The growth of the global demand for endoscopy products is encouraged by the growing incidence of chronic diseases, the development of endoscopy technologies, and expanded support and coverage for endoscopic screening and care.
The key players are Integrate Endoscopy, J&J services Inc, Cogentix Medical, Interscope Inc., Cantel Medical, Shaili Endoscopy, Cognetix, Stryker, PENTAX MEDICAL, Micro-Tech Endoscopy, FUJIFILM, OLYMPUS, KARL STORZ Gmbh & Co. KG, and RICHARD WOLF.
The therapies are gastroscopy, colonoscopy, ureteroscopy, laparoscopy, arthroscopy, endoscopic retrograde cholangiopancreatography, sigmoidoscopy, and cystoscopy.
The types studied are rigid endoscopes, flexible endoscopes, surgical endoscopes, capsule endoscopes, and robot-assisted endoscopes.
